MYB and neoplasm: Furthermore, both patients with a diagnosis of lacrimal gland ACC in our study possessed this gene fusion; 69.2% of patients had NFIB rearrangements, and 15.4% of tumor samples did not have rearrangements of MYB or NFIB genes on FISH analysis.